Powered Orthotic Exoskeleton Training in Stroke
POETS
Use of a Powered Orthotic Exoskeleton to Promote Mobility Through Improved Squat, Knee Flexion and Loading of the Paretic Leg in Persons With Chronic Stroke
2 other identifiers
interventional
22
1 country
1
Brief Summary
Veterans who suffer strokes often have disturbances in the ability to walk that reduces independence and quality of life. Alterations in gait combined with general decreased activity are associated with reduced muscle strength of the paretic leg. This leads to cardiovascular deconditioning and reduced quality of life. There is a new and novel battery powered device (Keeogo powered orthotic exoskeleton) that uses motors that assist knee movement while walking, sitting down, and standing up. The Keeogo monitors hip movement to assist the knee, making it simple to learn how to use. If successful, this project will show how this device will help improve the ability to walk and provide evidence to support larger clinical trials in a home and community setting to improve mobility, increase muscle mass and strength in the legs, as well as improve general health and quality of life. Lastly, this device could be used to increase motivation and confidence in a person to walk for longer periods of time and distance, providing the ability to walk in places that were previously inaccessible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Nov 2020
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2019
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedStudy Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedResults Posted
Study results publicly available
June 10, 2025
CompletedJune 10, 2025
May 1, 2025
3.6 years
December 30, 2019
April 3, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Five Times Sit to Stand Test (5xSTS)
The 5xSTS is used to determine leg power and an aspect of transfer skill. This test will be used to assess a level of improved function while wearing the device. The test will also be used to assess a level of improved function not while wearing the device.
Change from Baseline after completing 36 training sessions (approximately three months time)
Secondary Outcomes (8)
Energy Expenditure
Change from Baseline after completing 36 training sessions (approximately 3 months time)
The Ratio of Stance Time of Each Limb During Ambulation
Change from Baseline after completing 36 training sessions (approximately three months time)
Six Minute Walk Test (6MWT)
Change from Baseline after completing 36 training sessions (approximately three months time)
Ten Meter Walk Test (10MWT)
Change from Baseline after completing 36 training sessions (approximately three months time)
Timed Up and Go (TUG) Test
Change from Baseline after completing 36 training sessions (approximately three months time)
- +3 more secondary outcomes
Study Arms (2)
Powered Orthotic Exoskeleton Training Group
EXPERIMENTALParticipant in 36 session ambulation training using a powered orthotic exoskeleton.
Control Group
ACTIVE COMPARATORParticipant in 36 session ambulation training without using a powered orthotic exoskeleton.
Interventions
A new and novel type of robotic-device (Keeogo, B-temia, Inc.) was developed to provide powered assistance at the knee for persons with stroke. This device provides assistance for both knee extension and knee flexion during ambulation, transfers to standing and sitting, in addition to ascending and descending stairs. As this device isn't able to fully control the movement, it requires the ability of the patient to stand and initiate stepping. The approach the Keeogo uses to monitor the desired movement in order to appropriately provide assistance. This promotes intuitive learning for the user, minimizing the amount of instruction and practice needed to effectively ambulate allowing users to independently ambulate within one session. This device does not restrict leg movement, so the user can side-step and walk backwards. However, it does not provide assistance during these movements.
Ambulation training will consist of mobility activities affecting daily life including: walking; squatting (or getting in and out of a chair); bending, kneeling or stooping (for picking an item up off of the floor); and ascending and descending stairs. Sessions will be monitored and tailored to the individual, based on their functional ability and to ensure their safety.
Eligibility Criteria
You may qualify if:
- Males and female between 18 and 89 years old;
- Hemiplegia or hemiparesis due to stroke (\>6 months);
- \[Able to walk between 0.15-0.75m/s\]
- Self-reported limitations to mobility and walking activities due to paretic side knee stiffness and loss of range of motion;
- Weight under 250lbs
- Desire to increase daily activity levels; and
- Able and willing to commit to participation and follow directions and communicate basic needs.
You may not qualify if:
- Neurological paralysis causing an inability to stand, weight bear or take stepping movements;
- Fixed contractures resulting in limited range of motion in the hip, knees, or ankles that prevent sitting, standing, walking, and/or squatting activities;
- Modified Ashworth Scale for spasticity greater than 3 in the lower limbs
- Able to walk at a normal walking speed (1.4 m/s, 3.2 mph) or better during the Six Minute Walk Test (6MWT)
- Anthropometric incompatibility with the device
- Femur length less than 36 cm or greater than 45 cm;
- Upper thigh circumference less than 55 cm or greater than 75 cm;
- Lower thigh circumference less than 27 cm or greater than 40 cm;
- Calf circumference less than 33 cm or greater than 49 cm;
- Ankle circumference less than 27 cm or greater than 40 cm;
- Shin length less than 26 cm;
- Waist circumference less than 71 cm or greater than 107 cm;
- Any medical complication or co-morbidity as judged by the study physician to be contraindicated for wearing the device or walking (e.g., cardiovascular disorders, pressure ulcers, open wounds, lower limb vascular disorders, or other medical conditions); and
- Pregnant or planning to become pregnant (Females only).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
We were approved to begin this study during the summer of 2020, which was during the first wave of the COVID-19 pandemic. Due to the lockdown status of our VAMC at that time, no participants were permitted to be enrolled. In late April 2021, most restrictions were lifted at our VAMC, and we were able to begin the process of enrolling the targeted number of participants. The delayed start to study procedures, however, led to a smaller than anticipated number of subjects available for analysis.
Results Point of Contact
- Title
- Dr. Ann Spungen
- Organization
- James J. Peters VA Medical Center, Spinal Cord Damage Research Center
Study Officials
- PRINCIPAL INVESTIGATOR
Ann M Spungen, EdD
James J. Peters Veterans Affairs Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2019
First Posted
January 27, 2020
Study Start
November 2, 2020
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
June 10, 2025
Results First Posted
June 10, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Where practicable, sharing should take place under a written agreement prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. However, it is permissible for final datasets in machine-readable format to be submitted to and accessed from PubMed Central (and similar sites) provided that care is taken to ensure that the individuals cannot be re-identified using other publicly available information.